Description

CJC‑1295 – Growth Hormone Releasing Peptide

Overview
CJC‑1295 is a synthetic peptide designed to stimulate the body’s natural production of growth hormone by activating growth hormone‑releasing hormone (GHRH) receptors. It typically has a shorter active duration compared to its DAC‑modified counterpart, often requiring more frequent dosing. It is used in research settings to support increases in growth hormone levels.

Benefits

• Supports increased natural growth hormone release
• May aid in muscle growth and preservation
• Can enhance recovery from training and injury
• May improve fat metabolism and body composition
• Can contribute to improved energy and overall vitality

Mechanism of Action
CJC‑1295 works by binding to GHRH receptors, signaling the pituitary gland to release growth hormone more frequently. This can help trigger pulses of growth hormone throughout the day, supporting metabolic and anabolic processes.

Dosing (Research Use Only)

• Typical dose: 1000–2000 mcg per week
• Frequency: Often divided into 2–3 smaller doses per week
• Administration: Subcutaneous injection
• Cycle length: Commonly 8–12 weeks or as determined by research protocols
• Injection sites: Abdomen, thigh, or upper arm with rotation between sites
  Because it has a shorter half‑life, more frequent injections are used to maintain consistent growth hormone stimulation.

Expected Results

• Growth hormone increases typically begin after the first week
• Improvements in recovery, muscle tone, and energy may appear within a few weeks
• Fat metabolism and changes in body composition usually develop over the course of a cycle

Side Effects

• Injection site redness or irritation
• Mild water retention
• Temporary tiredness or headache
• Possible increase in hunger
• Rare: tingling or numbness in extremities
  Most side effects are mild and tend to occur early in use or with higher doses.

Warnings

• Experimental peptide not approved for general medical use
• Not recommended during pregnancy or breastfeeding
• Individuals with endocrine or metabolic disorders should consult a healthcare professional before use
• Changes in growth hormone can influence glucose metabolism and fluid balance

Summary
CJC‑1295 is a growth hormone‑releasing peptide used to support increased endogenous growth hormone production. It is typically administered multiple times per week and may aid in recovery, muscle support, fat metabolism, and general vitality. While generally well tolerated in research contexts, it remains experimental and lacks comprehensive long‑term human safety data.